ReviewLife (Basel, Switzerland)2026
A Paradigm Shift in Microbial Protein Manufacturing.
Review in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Against the backdrop of the global protein crisis and the textural limitations of alternative proteins, microorganisms are increasingly recognized as versatile structural materials to address these challenges. This review systematically analyzes three key microbial strategies: employing mycelial solid-state fermentation to engineer fibrous meat analogues; utilizing bacterial cellulose scaffolds to enhance the texture of both cultured meat and plant-based products; and applying synthetic biology to design tailored functional proteins. Existing studies confirm that mycelial fermentation significantly improves product texture and production sustainability. In parallel, bacterial cellulose provides highly biocompatible nanoscaffolds, while synthetic biology enables the efficient production and nutritional enhancement of complex animal proteins. Although challenges in scaling production and optimizing flavor persist, advanced bioprocess optimization and genetic engineering offer promising solutions. Future breakthroughs are expected to transition from structural mimicry to true functional creation, establish decentralized production networks, and advance dynamic 4D-printed foods, which will collectively contribute to a more sustainable and resilient global food system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.